$VXRT B. Riley FBR initiated coverage of Vaxart with a Buy rating and $22 price target. https://t.co/00tHiV3Mxj #Stocks #StockMarket #biotech #biotechnology #COVID19 #Vaccine #coronavaccine https://t.co/Albs8uY7G6